New York, U.S., Sept. 26, 2022 (GLOBE NEWSWIRE) — The global market value of sepsis diagnostics was US$712.74 million in 2021 and will reach US$1509.85 million at a CAGR of 8 by 2030 reach .7%. Sepsis is a serious condition that occurs when the body responds to an infection that causes tissue damage. Bacterial infections are the main cause of sepsis, while viral infections can also lead to sepsis. A postoperative infection or a small wound that becomes infected can trigger sepsis. Sepsis can lead to multiple organ failure, septic shock, and death if not properly diagnosed and treated.

To get a first-hand look at the report, request a sample at
https://www.strategicmarketresearch.com/request-sample/sepsis-diagnostics-market

Sepsis Diagnostics Market Insights:

• In terms of product, the blood culture media segment occupied a dominant position in 2021 with a market share of over 45.5%.
• Technology-based, the microbiology segment recorded a maximum share of sales of over 48.5%.
• The segment of bacterial sepsis took a dominant position in 2021 with a sales share of almost 79.5% among the pathogens.
• Based on the test type, the laboratory test start segment had the highest share of sales in 2021 with over 85%.
• North America dominated the overall market by region with a revenue share of almost 39.7% in 2021.

Factors influencing the growth of the Sepsis Diagnostics market:

factors like the increasing occurrence of infectious diseases and hospital infections affect its growth rate.

• Factors such as the increasing cases of infectious diseases like cholera, pneumonia, salmonellosis, toxic shock syndrome, COVID-19 and other diseases are stimulating the overall growth of the sepsis diagnostics market. According to the World Health Organization as of February 2021, approximately 1.3 to 4.0 million cases of cholera are recorded worldwide each year. In addition, a study by the National Center for Biotechnology Information (NCBI) in November…